Maryanne Quinn is an Endocrinology/Metabolic physician affiliated with Boston Children's Hospital. OpenAlex indexes 22 publications with 1,778 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Longwood Ave
Boston, MA 021155724
Telephone
617-355-8828Registry record last updated 11 Sept 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Tandem Diabetes Care, Inc.Program year20251 payment
- Sequel Med Tech, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
100%l-Thyroxine100%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1994–2006 per NIH RePORTER. The latest:
- GENETIC AND ENVIORMENTAL RISK FACTORS FOR TYPE 1 DIABETES MELLITUS
Boston Children'S Hospital
FY2006$39,877M01RR002172 - GENETIC AND ENVIORMENTAL RISK FACTORS FOR TYPE 1 DIABETES MELLITUS
Children'S Hospital Boston
FY2005$37,039M01RR002172 - Genetic and Environmental Risk Factors for Type 1 Diabet
Children'S Hospital Boston
FY2004$6,702M01RR002172
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Stuart Orkin, MD
Boston Children's Hospital
Jane Newburger, MD
Boston Children's Hospital
Michael Landzberg, MD
Boston Children's Hospital
Stephen Sallan, MD
Boston Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”